Deep Learning for Drug Discovery and Cancer Research: Automated Analysis of Vascularization Images
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Likely drug candidates which are identified in traditional pre-clinical drug screens often fail in patient trials, increasing the societal burden of drug discovery. A major contributing factor to this phenomenon is the failure of traditional in vitro models of drug response to accurately mimic many of the more complex properties of human biology. We have recently introduced a new microphysiological system for growing vascularized, perfused microtissues that more accurately models human physiology and is suitable for large drug screens. In this work, we develop a machine learning model that can quickly and accurately flag compounds which effectively disrupt vascular networks from images taken before and after drug application in vitro. The system is based on a convolutional neural network and achieves near perfect accuracy while committing potentially no expensive false negatives.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ImageNet classification with deep convolutional neural networks
Krizhevsky, A., Sutskever, I., & Hinton, G. E. (2017) · Communications of the ACM · doi:10.1145/3065386 · Cited by 112,155
Faster R-CNN: Towards Real-Time Object Detection with Region Proposal Networks
Ren, S., He, K., Girshick, R., & Sun, J. (2017) · IEEE Transactions on Pattern Analysis and Machine Intelligence · doi:10.1109/tpami.2016.2577031 · Cited by 73,472
Practical Bayesian Optimization of Machine Learning Algorithms
Snoek, J., Larochelle, H., & Adams, R. P. (2012) · arXiv · doi:10.48550/arxiv.1206.2944 · Cited by 6,691
Reconstituting organ-level lung functions on a chip
Huh, D., Matthews, B. D., Mammoto, A., Montoya-Zavala, M., Hsin, H. Y., & Ingber, D. E. (2010) · Science · doi:10.1126/science.1188302 · Cited by 4,250 · cited 1×
“[8], [9], [10], [11], [12], supported in part through private-public partnerships fostered under the auspices of the National Center for Advancing Translation Science [13].”
Diagnosing the decline in pharmaceutical R&D efficiency
Scannell, J. W., Blanckley, A., Boldon, H., & Warrington, B. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3681 · Cited by 1,981 · cited 1×
“has exhibited a steady, exponential rise over the past five decades [1].”
Organs-on-chips at the frontiers of drug discovery
Esch, E. W., Bahinski, A., & Huh, D. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4539 · Cited by 1,185 · cited 1×
“Microphysiological systems (MPSs), or “organ-on-a-chip” platforms, promise to help close the gap between in vitro and in vivo drug screens [5], [6], [7], and have seen rapid, recent development”
Deep Learning in Drug Discovery
Gawehn, E., Hiss, J. A., & Schneider, G. (2016) · Molecular Informatics · doi:10.1002/minf.201501008 · Cited by 723
Phase II and Phase III attrition rates 2011–2012
Arrowsmith, J., & Miller, P. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4090 · Cited by 697 · cited 1×
“In short, a compound that appears effective in traditional, pre-clinical studies may fail spectacularly in the human body, further contributing to the costly societal burden of failed clinical trials [4].”
3D microtumors in vitro supported by perfused vascular networks
Sobrino, A., Phan, D. T. T., Datta, R., Wang, X., Hachey, S. J., Romero-López, M., Gratton, E., Lee, A. P., George, S. C., & Hughes, C. C. W. (2016) · Scientific Reports · doi:10.1038/srep31589 · Cited by 387 · cited 2×
“Drug studies were performed in the MPS as previously described [16], [17].”
Self-citationA vascularized and perfused organ-on-a-chip platform for large-scale drug screening applications
Phan, D. T. T., Wang, X., Craver, B. M., Sobrino, A., Zhao, D., Chen, J. C., Lee, L. Y. N., George, S. C., Lee, A. P., & Hughes, C. C. W. (2017) · Lab on a Chip · doi:10.1039/c6lc01422d · Cited by 325 · cited 2×
“Drug studies were performed in the MPS as previously described [16], [17].”
Self-citation
Cited by
Quo vadis artificial intelligence?
Jiang, Y., Li, X., Luo, H., Yin, S., & Kaynak, O. (2022) · Discover Artificial Intelligence · doi:10.1007/s44163-022-00022-8 · Cited by 544
Organ-on-a-chip meets artificial intelligence in drug evaluation
Deng, S., Li, C., Cao, J., Cui, Z., Du, J., Fu, Z., Yang, H., & Chen, P. (2023) · Theranostics · doi:10.7150/thno.87266 · Cited by 260
Applications of tumor chip technology
Hachey, S. J., & Hughes, C. C. W. (2018) · Lab on a Chip · doi:10.1039/c8lc00330k · Cited by 128
Self-citationSung, J. H., Wang, Y., & Shuler, M. L. (2019) · APL Bioengineering · doi:10.1063/1.5097675 · Cited by 66
Zhuang, D., & Ibrahim, A. K. (2021) · Applied Sciences · doi:10.3390/app11177772 · Cited by 33
Metadata
- Authors
- Urban, G., Bache, K., Phan, D. T. T., Sobrino, A., Shmakov, A. K., Hachey, S. J., Hughes, C. C. W., & Baldi, P.
- Venue
- IEEE/ACM Transactions on Computational Biology and Bioinformatics
- Published
- 2019-05-01
- Volume
- 16
- Issue
- 3
- Pages
- 1029-1035
- ISSN
- 1545-5963 (ISSN-L)
- 1557-9964
- 2374-0043
- OpenAlex
- W2806887204
- Cited by
- 63
- References
- 11
- FWCI
- 3.39
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Deep Learning for Drug Discovery and Cancer Research: Automated Analysis of Vascularization Images. https://app.cochat.ai/papers/10.1109/tcbb.2018.2841396
- The paper
- Urban, G., Bache, K., Phan, D. T. T., Sobrino, A., Shmakov, A. K., Hachey, S. J., Hughes, C. C. W., & Baldi, P. (2019). Deep Learning for Drug Discovery and Cancer Research: Automated Analysis of Vascularization Images. IEEE/ACM Transactions on Computational Biology and Bioinformatics. https://doi.org/10.1109/tcbb.2018.2841396
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.